"As the first imaging-based biomarker of aging with single-cell resolution, this is the first time we've been able to observe aging at such a granular level," Dr. Ninomiya said.

Researchers have developed a new way to study disease at the cellular level. Dr. Keith Cheng, distinguished professor of pathology, pharmacology and biochemistry and molecular biology at Penn ...